Regulation of distinct steps of angiogenesis by different angiogenic molecules

International Journal of Oncology

Volumn 12, Issue 4, 1998, Pages 749-757

  Kumar, Rakesh ^a   Yoneda, Junya ^a   Bucana, Corazon D ^a   Fidler, Isaiah J ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Angiogenesis; Basic fibroblast growth factor; Hepatocyte growth factor; Interleukin 8; Platelet derived endothelial cell growth factor; Platelet derived growth factor; Vascular endothelial growth factor vascular permeability factor

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; COLLAGENASE; INTERLEUKIN 8; PLATELET DERIVED ENDOTHELIAL CELL GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR; SCATTER FACTOR; UROKINASE; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CELL DIVISION; CELL MEMBRANE PERMEABILITY; CELL MIGRATION; CELL SURVIVAL; CHEMOTAXIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

EID: 0031915348     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.12.4.749     Document Type: Article

References (81)

1. Folkman J: Angiogenesis in cancer, vascular, rheumatoid, and other diseases. Nat Med 1: 27-31, 1991.
2. Auerbach W and Auerbach R: Aneiogenesis inhibition: a review. Pharmacol Ther 63: 265-311, 1994.
3. Cockerill GW, Gamble JR and Vadas MA: Angiogenesis: models and modulators. Int Rev Cytol 159: 113-160, 1995.
4. Folkman J: Tumor angiogenesis. In: The Molecular Basis of Cancer. Mendelsohn J, Howley PM, Israel MA and Liotta LA (eds). Philadelpia, WB Saunders Co, pp206-232, 1995.
5. Hanahan D and Folkman J: Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86: 353-364, 1996.
6. Bouck N, Stellmach V and Hsu S.C: How tumors become angiogenic. Adv Cancer Res 69: 135-174, 1996.
7. Folkman J: Clinical applications of research on angiogenesis. N Engl J Med 333: 1753-1763, 1995.
8. Folkman J and Klagsbum M: Angiogenic factors. Science 235: 442-447, 1987.
9. Shing Y, Folkman J, Haudenschild C, Lund D, Crum R and Klagsbrun M: Angiogenesis is stimulated by a tumor-derived endothelial cell growth factor. J Cell Biochem 29: 275-287, 1985.
10. Leung ZW, Cachianes G, Kuang WJ, Goeddel DV and Ferrara N: Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246: 1306-1309, 1989.
11. Connolly DT, Heuvelman DM, Nelson R, Olander JV, Eppley BL, Delfino JJ, Siegel NR, Leimgruber RM and Feder J: Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 84: 1470-1478, 1989.
12. Plate KH, Breier G, Weich HA and Risau W: Vascular endothelial growth factor is a potential tumor angiogenesis factor in human gliomas in vivo. Nature 359: 845-848, 1992.
13. Dvorak HF, Brown LF, Detmar M and Dvorak AM: Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146: 1029-1039, 1995.
14. Koch AE, Polverini PJ, Kunkel SL, Harlow LA, diPietro LA, Einer LM, Einer SG and Stricter RM: Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 258: 1798-1801, 1992.
15. Ishikawa F, Miyazone K, Hellman U, Drexler H, Wernstedt C, Hagiwara K, Usuki K, Takaku F, Risau W and Heldin C-H: Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature 338: 557-562, 1989.
16. Bussolino F, diRenzo MF, Ziehe M, Bocchietto E, Olivero M, Naldini L, Gaudino G, Tamagone L, Coffer A and Comoglio PM: Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol 119: 629-641, 1992.
17. Rosen EM, Grant DS, Kleinman HK, Goldberg ID, Bhargara MM, Nichollof EJ, Kinsella JL and Polverini P: Scatter factor (hepatocyte growth factor) is a potent angiogenic factor in vivo. Symp Soc Exp Biol 47: 227-234, 1993.
18. Grant DS, Kleinman HK, Goldberg ID, Bhargara MM, Nichollof EJ, Kinsella JL, Polverini P and Rosen EM: Scatter factor induces blood vessel formation in vivo. Cell Biol 90: 1937-1941, 1993.
19. Heldin C-H: Structural and functional studies on platelet-derived growth factor. EMBO J 11: 4251-4259, 1992.
20. Risau W, Drexler H, Mironov V, Smits A, Funa K and Heldin C-H: Platelet-derived growth factor is angiogenic in vivo. Growth Factors 7: 261-266, 1992.
21. Holmgren L, Glaser A, Pfeifer-Ohlsson S and Ohlsson R: Angiogenesis during extraembryonic development involves the spatiotemporal control of PDGF ligand and receptor gene expression. Development 113: 749-754, 1991.
22. Moghaddam A, Zhang H-T, Fan T-PD, Hu D-E, Lees VC, Turley H, Fox SB, Gatter KC, Harris AL and Bicknell R: Thymidine phosphorylase is angiogenic and promotes tumor growth. Proc Natl Acad Sci USA 92:998-1002, 1995.
23. Kleinman HK, McGarvey ML, Hassel JR, Star VL, Cannon FB, Laurie GW and Martin GR: Basement membrane complexes with biological properties. Biochemistry 25: 312-318, 1986.
24. Fan D, Chakrabarty S, Seid C, Bell CW, Schackert H, Morikawa K and Fidler IJ: Clonal stimulation or inhibition of human colon carcinomas and human renal carcinomas mediated by transforming growth factor-ß 1. Cancer Commun 1: 117-125, 1989.
25. Fan D, Bucana CD, O'Brian CA, Zwelling L, Seid C and Fidler IJ: Enhancement of murine tumor cell sensitivity to Adriamycin by presentation of the drug in phosphatidylcholine-phosphatidylserine in liposomes. Cancer Res 50: 3619-3626, 1990.
26. Kubota Y, Kleinman HK, Martin GR and Lawley TJ: Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary-like structures. J Cell Biol 107: 1589-1598, 1988.
27. Matsumura T, Wolff K and Petzelbauer P: Endothelial cell tube formation depends on cadherin 5 and CD31 interactions with filamentous actin. J Immunol 158: 3408-3416, 1997.
28. Radinsky R, Kraemer PM, Raines MA, Xung HJ and Culp LA: Amplification and rearrangement of Kirsten rai oncogene in virus transformed BALB/3T3 cells during malignant tumor progression. Proc Natl Acad Sci USA 84: 5143-5147, 1987.
29. Boyden SV: The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leukocytes. J Exp Med 115: 453-466, 1962.
30. Albrecht-Buehler G: The phagokinetic tracks of 3T3 cells. Cell 11: 395-404, 1977.
31. Killackey JJF, Johnston MG and Movat HZ: Increased permeability of microcarrier-cultured endothelial monolayers in response to histamine and thrombin: a model for the in vitro study of increased vasopermeability. Am J Pathol 122: 50-61, 1986.
32. Rutten MJ, Hoover RL and Kamovsky MJ: Electrical resistance and macromolecular permeability of brain endothelial monolayer cultures. Brain Res 425: 301-310, 1987.
33. Araki S, Shimada Y, Kaji K and Hayashi H: Apoptosis of vascular endothelial cells by fibroblast growth factor deprivation. Biochem Biophys Res Commun 168: 1194-1200, 1990.
34. Araki S, Simada Y, Kaji K and Hayashi H: Role of protein kinase C in the inhibition by fibroblast growth factor of apoptosis in serum-depleted endothelial cells. Biochem Biophys Res Commun 172: 1081-1085, 1990.
35. Alon T, Hemo I, Itin A, Pe'er J, Stone J and Keshet E: Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med 1: 1024-1028, 1995.
36. Benjamin LE and Keshet E: Conditioned switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal. Proc Natl Acad Sci USA 94: 8761-8766, 1997.
37. Prehn RT: Many growth factors may not be growth factors. Cancer Res 52: 501-507, 1992.
38. Sell C, Baserga R and Rubin R: Insulin-like growth factor (IGF-1) and the IGF-1 receptor prevent etoposide-induced apoptosis. Cancer Res 55: 303-306, 1995.
39. Senger DR: Molecular framework for angiogenesis: a complex web of interactions between extravasated plasma proteins and endothelial cell proteins induced by angiogenic cytokines. Am J Pathol 149: 1-7, 1996.
40. Folkman J and Shing Y: Angiogenesis. J Biol Chem 267: 10931-10934, 1992.
41. Zoellner H, Hofler M, Beckmann R, Hufang P, Vanyek E, Bielek E, Wojta J, Fabry A, Lockic S and Binder BR: Serum albumin is a specific inhibitor of apoptosis in human endothelial cells. J Cell Sci 109: 2571-2580, 1996.
42. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS and Dvorak HF: Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219: 983-985, 1983.
43. Ferrara N, Houck KA, Jakeman LB, Winer J and Leung DW: The vascular endothelial growth factor family of polypeptides. J Cell Biochem 47: 211-218, 1991.
44. Yoshida A, Anand-Apte B and Zetter BR: Differential endothelial cell migration and proliferation to basic fibroblast growth factor and vascular endothelial growth factor. Growth Factors 13: 57-64, 1996.
45. Zetter BR: Cell motility in angiogenesis and tumor metastasis. Cancer Invest 8: 669-671, 1990.
46. Liotta LA, Thorgeirrson UP and Garbisa S: Role of collagenases in tumor cell invasion. Cancer Metastasis Rev 1: 277-288, 1982.
47. Garbisa S, Pozatti R, Muschel RJ, Safiotti U, Ballin M, Goldfarb RH, Khoury G and Liotta LA: Secretion of type IV collagenolytic protease and metastatic phenotype: induction by transfection with c-Ha-ras but not c-Ha-ras plus Ad2-Ela. Cancer Res 47: 1523-1528, 1987.
48. Carlson SA, Ramshaw IA and Warrinton RC: Involvement of plasminogen activator production with tumor metastasis in a rat model. Cancer Res 44: 1122-1127, 1984.
49. Ossowoski L and Reich E: Antibodies to plasminogen activator inhibit human tumor metastasis. Cell 35: 611-619, 1983.
50. Singh RK, Reich R, Radinsky R, Berry KK, Dave BJ and Fidler IJ: Expression of basic fibroblast growth factor is necessary but insufficient for production of metastasis. Int J Oncol 10: 23-31, 1997.
51. Pepper MS, Ferrara N, Orci L and Montesano R: Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem Biophys Res Commun 181: 902-906, 1991.
52. Stoker M and Perryman M: An epithelial scatter factor released by embryo fibroblasts. J Cell Sci 77: 209-223, 1985.
53. Vernon RB and Sage H: Between molecules and morphology: extracellular matrix and creation of vascular form. Am J Pathol 147: 873-883, 1995.
54. Collins PD, Connolly DT and Williams TJ: Characterization of the increase in vascular permeability induced by vascular permeability factor in vivo. Br J Pharmacol 109: 195-199, 1993.
55. Feng D, Nagy JA, Hipp J, Dvorak HF and Dvorak AM: Vesiculo-vacuolar organelles (VVOs) and the regulation of venule permeability to macromolecules by vascular permeability factor, histamine, and serotonin. J Exp Med 183: 1981-1986, 1996.
56. Roberts WG and Palade GE: Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci 108: 2369-2379, 1995.
57. Mardebo JE and Kahrstrum J: Endothelial negative surface charge areas and blood-brain barrier function. Acta Physiol Scand 125: 495-499, 1985.
58. Dellian M, Witwer BP, Salehi HA, Yuan F and Jain RK: Quantitation and physiological characterization of angiogenic vessels in mice: effect of basic fibroblast growth factor, vascular endothelial growth factor/vascular permeability factor, and host microenvironment. Am J Pathol 149: 59-71, 1996.
59. Stavri AT, Zachary IC, Baskerville PA, Martin JF and Erusalimsky JD: Basic fibroblast growth factor upregulates the expression of vascular endothelial growth factor in vascular smooth muscle cells: synergistic interaction with hypoxia. Circulation 92: 11-14, 1995.
60. Shweiki D, Itin A, Soffer D and Keshet E: Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359: 843-845, 1992.
61. Sunderkötter C, Steinbrink K, Goebeler M, Bhardwaj R and Sorg C: Macrophages and angiogenesis. J Leukocyte Biol 55: 410-422, 1994.
62. Slavin J: The role of cytokines in wound healing. J Pathol 178: 5-10, 1996.
63. Polverini PJ and Leibovich JS: Induction of neovascularization in vivo and endothclial proliferation in vitro by tumor-associated macrophages. Lab Invest 51: 635-642, 1984.
64. Gutman M, Singh RK, Yoon S, Xie K, Bucana CD and Fidler IJ: Leukocyte-induced angiogenesis and subcutaneous growth of B16 melanoma. Cancer Biother 9: 163-170, 1994.
65. Leek RD, Harris AL and Lewis CE: Cytokine networks in solid human tumors: regulation of angiogenesis. J Leukocyte Biol 56: 423-435, 1994.
66. Brown LF, Berse B, Jackman RW, Tognazzi K, Manseau EJ, Senger DR and Dvorak HF: Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Res 53: 4727-4735, 1993.
67. Yoshiji H, Gomez DE, Shibuya M and Thorgeirsson UP: Expression of vascular endothelial growth factor, its receptor, and other angiogenic factors in human breast cancer. Cancer Res 56: 2013-2016, 1996.
68. Takahashi Y, Kitadai Y, Bucana CD, Cleary KR and Ellis LM: Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res 55: 3964-3968, 1995.
69. Xerri L, Bettyeni Z, Grob JJ, Perc P, Hassoun J, Bonerandi JJ and Birnbaum D: Expression of FGFI and FGFRI in human melanoma tissues. Melanoma Res 6: 223-230, 1996.
70. Takanami I, Tanaka F, Hashizume T, Kikuchi K, Yamamoto Y, Yamamoto T and Kodaira S: The basic fibroblast growth factor and its receptor in pulmonary adenocarcinomas: an investigation of their expression as prognostic markers. Eur J Cancer 32A: 1504-1509, 1996.
71. Engerman RL, Pfaffenbach D and Davis MD: Cell turnover of capillaries. Lab Invest 17: 738-743, 1967.
72. Hobson B and Denekamp J: Endothelial proliferation in tumours and normal tissues: continuous labelling studies. Br J Cancer 49: 405-413, 1984.
73. Singh RK, Llansa N, Bucana CD, Sanchez R, Koura A and Fidler IJ: Cell density-dependent regulation of basic fibroblast growth factor expression in human renal cell carcinoma cells. Cell Growth Differ 7: 397-404, 1996.
74. Koura AN, Liu W, Kitadai Y, Singh RK, Radinsky R and Ellis LM: Regulation of vascular endothelial growth factor expression in human colon carcinoma cells by cell density. Cancer Res 56: 3891-3894, 1996.
75. Kitadai Y, Ellis LM, Takahashi Y, Bucana CD, Anzai H, Tahara E and Fidler IJ: Multiparametric in situ messenger RNA hybridization analysis to detect metastasis-related genes in surgical specimens of human colon carcinomas. Clin Cancer Res 1: 1095-1102, 1995.
76. Swerlick RA, Lee KH, Li LJ, Sepp NT, Caughman SW and Lawley TJ: Regulation of vascular cell adhesion molecule 1 on human dermal microvascular endothelial cells. J Immunol 149: 698-705, 1992.
77. Hitraya EG, Tan EM, Rudnicka L and Jimenez SA: Expression of extracellular matrix genes in adult human dermal microvascular endothelial cells and their regulation by heparin and endothelial cell mitogens. Lab Invest 73: 393-402, 1995.
78. Haraldsen A, Kvale D, Lien B, Farstad IN and Brahdtzaeg P: Cytokine-regulated expression of E-selectin, intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) in human microvascular endothelial cells. J Immunol 156: 2558-2565, 1996.
79. Auerbach R, Alby L, Morrissey LW, Tu M and Joseph J: Expression of organ-specific antigens on capillary endothelial cells. Microvascular Res 29: 401-411, 1985.
80. Gumkowski F, Kaminska G, Kaminski M, Morrissey LW and Auerbach R: Heterogeneity of mouse vascular endothelium. In vitro studies of lymphatic, large blood vessel and microvascular endothelial cells. Blood Vessels 24: 11-23, 1987.
81. McLean JW, Fox EA, Baluk P, Bolton PB, Haskell A, Peralman R, Thurston G, Umemoto EY and McDonald DM: Organ-specific endothelial cell uptake of cationic liposome-DNA complexes in mice. Am J Pathol 273: H387-H404, 1997.